The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 24.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 66% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 228%. Our forward projection puts the odds of a 10% gain over the next month near 37%. The street (9 analysts) rates it buy, with a mean price target of $145.
FormFactor Inc FORM
Clears both ethical standards
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · FormFactor, Inc.
read at $131.67
FormFactor Inc holds its Markup at $131.67.
- PHPhase · the trend structure carries the Markup label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · passes the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Markup |
| Quantitative state | The statistical read favours the sellers, held for 5 days |
| Price | $131.67 |
| Valuation | 90.81 trailing · 37.89 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 1.25 |
The opportunity · what the numbers say it is worth
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish — a quality-at-a-fair-price name rather than a deep-value one.
| Revenue growth | 31.90% |
| Profit margin | 12.80% |
| Debt to equity | 2.69 |
| Analyst consensus | Buy · 8 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company clears both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. Here is how it did on each:
Used by most halal investing apps ✓ PASSES
The one Titan applies ✓ PASSES
What these two standards are, and how they differ →
- Business activity Its core business isn't built on prohibited lines — no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
- Debt load Interest-bearing debt is just 2.6% of its assets, well under the one-third ceiling — it does not run on borrowed money. Pass
- Interest-bearing cash Cash held in interest-bearing accounts and securities is 14.0% of assets, under the one-third limit. Pass
- Receivables Money owed to the company is 18.7% of assets, under the 49% limit. Pass
- Revenue purity Only 1.4% of revenue comes from non-compliant sources — under the 5% line. Pass
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Probe Card Maker Priced for a Boom That May Not Last
Every chip that powers your phone or car must be tested before it ships, and FormFactor builds the delicate probe cards that do that checking. Demand surges when semiconductor plants expand, then vanishes when cycles turn. The company is posting 32% revenue growth and clearing an ethical screen, yet none of that changes the fact that shares sit 15% above our fair value at a 37.8 times forward multiple.
We pass. A weak moat, 7% ROE and 8% profit margins leave little room for error in a business whose fortunes track capital spending by chipmakers. The low single-digit return on equity already signals thin pricing power, and paying a premium multiple on peak-cycle earnings simply compounds the problem.
The real risk is the classic cyclical trap. When equipment orders slow, both revenue and the multiple can fall together, turning what looks like growth into a sharp drawdown. Even with a consensus buy rating from nine analysts, the numbers show a business valued for perfection it has not yet delivered. Analysis, not advice.
| Forward P/E | 37.9x fairly priced for its growth rate |
| Trailing P/E | 90.8x expensive — the price assumes strong growth ahead |
| Revenue growth | 31.9% strong top-line growth |
| Profit margin | 12.8% thin but positive margins |
| Return on equity | 11.0% a modest return on shareholder capital |
| Debt to equity | 2.69 heavy leverage — higher risk if revenue softens |
| Current ratio | 4.08 comfortably covers its short-term bills |
| Beta | 1.25 moves a little more than the market |
| Market cap | $10.3B |
| Employees | 2,153 |
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Related securities · others in FORM's space worth a look
Screened names in the same industry · explore each on its own page.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 66% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 228%. Our forward projection puts the odds of a 10% gain over the next month near 37%. The street (9 analysts) rates it buy, with a mean price target of $145.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
The political ledger · congressional disclosures
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 9 Apr2026 | Josh Gottheimer | Democrat | sell | 15K–50K |
| 4 Jun2026 | John McGuire | Republican | buy | 1K–15K |
| 31 Jul2026 | April McClain Delaney | Democrat | buy | 15K–50K |
| 29 Jul2026 | April McClain Delaney | Democrat | buy | 1K–15K |
| 28 Jul2026 | April McClain Delaney | Democrat | buy | 15K–50K |
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $151.40 | -23.7% | · | $763 | -23.7% |
| 2 months | $123.80 | -6.7% | · | $933 | -6.7% |
| 3 months | $88.40 | +30.7% | · | $1,307 | +30.7% |
| 6 months | $58.13 | +98.7% | · | $1,987 | +98.7% |
| 1 year | $35.20 | +228.2% | · | $3,282 | +228.2% |
| 2 years | $54.08 | +113.6% | · | $2,136 | +113.6% |
| 3 years | $30.46 | +279.3% | · | $3,793 | +279.3% |
| 5 years | $33.82 | +241.6% | · | $3,416 | +241.6% |
Historical returns from market close data. Past performance does not guarantee future results.